DK183583A - Fremgangsmaade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner - Google Patents

Fremgangsmaade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner Download PDF

Info

Publication number
DK183583A
DK183583A DK183583A DK183583A DK183583A DK 183583 A DK183583 A DK 183583A DK 183583 A DK183583 A DK 183583A DK 183583 A DK183583 A DK 183583A DK 183583 A DK183583 A DK 183583A
Authority
DK
Denmark
Prior art keywords
benzoazacycloalkyl
imidazolidines
spiro
preparing
procedure
Prior art date
Application number
DK183583A
Other languages
Danish (da)
English (en)
Other versions
DK183583D0 (da
Inventor
Charles Malen
Jean-Louis Peglion
Jacques Duhault
Michelle Boulanger
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of DK183583D0 publication Critical patent/DK183583D0/da
Publication of DK183583A publication Critical patent/DK183583A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK183583A 1982-04-27 1983-04-26 Fremgangsmaade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner DK183583A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8207203A FR2525603A1 (fr) 1982-04-27 1982-04-27 Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique
FR8207203 1982-04-27

Publications (2)

Publication Number Publication Date
DK183583D0 DK183583D0 (da) 1983-04-26
DK183583A true DK183583A (da) 1983-10-28

Family

ID=9273425

Family Applications (1)

Application Number Title Priority Date Filing Date
DK183583A DK183583A (da) 1982-04-27 1983-04-26 Fremgangsmaade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner

Country Status (22)

Country Link
JP (1) JPS5910584A (enExample)
KR (1) KR840004428A (enExample)
AT (1) ATA125383A (enExample)
AU (1) AU1395383A (enExample)
BE (1) BE896572A (enExample)
DD (1) DD209833A5 (enExample)
DE (1) DE3315106A1 (enExample)
DK (1) DK183583A (enExample)
ES (1) ES521895A0 (enExample)
FR (1) FR2525603A1 (enExample)
GB (1) GB2133401B (enExample)
GR (1) GR78481B (enExample)
IL (1) IL68497A0 (enExample)
IT (1) IT1167123B (enExample)
LU (1) LU84770A1 (enExample)
MA (1) MA19783A1 (enExample)
NL (1) NL8301476A (enExample)
NO (1) NO831473L (enExample)
OA (1) OA07412A (enExample)
PT (1) PT76595B (enExample)
SE (1) SE8302347L (enExample)
ZA (1) ZA832927B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US4927831A (en) * 1988-10-20 1990-05-22 American Home Products Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
MXPA05013364A (es) 2003-06-17 2006-03-17 Arena Pharm Inc Procedimiento para preparar 3-benzazepinas.
AU2004253888B2 (en) 2003-06-17 2010-11-11 Arena Pharmaceuticals, Inc. Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
PT1838677E (pt) 2004-12-21 2009-11-16 Arena Pharm Inc Formas cristalinas do cloridrato de (r)-8-cloro-1-metil- 2,3,4,5-tetra-hidro-1h-3-benzazepina
SI1833473T1 (sl) 2004-12-23 2010-01-29 Arena Pharm Inc Sestavki modulatorjev 5HT2C receptorjev in postopki uporabe
WO2007120517A2 (en) 2006-04-03 2007-10-25 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
US8299241B2 (en) 2006-12-05 2012-10-30 Arena Pharmaceuticals, Inc. Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
JP5491421B2 (ja) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストである(r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンに関連する中間体の調製のためのプロセス
CN102648170A (zh) 2009-06-18 2012-08-22 艾尼纳制药公司 制备5-ht2c受体激动剂的方法
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ht2c 수용체 아고니스트의 제조 방법
JP6272695B2 (ja) 2010-09-01 2018-01-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 体重管理のために有用な5−ht2cアゴニストの改変放出剤形
WO2012030938A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
CA2808890A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Administration of lorcaserin to individuals with renal impairment
SG188361A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Non-hygroscopic salts of 5-ht2c agonists
JP2015534563A (ja) 2012-10-09 2015-12-03 アリーナ ファーマシューティカルズ, インコーポレイテッド 体重管理の方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209630A (en) * 1976-10-18 1980-06-24 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
SE8302347L (sv) 1983-10-28
OA07412A (fr) 1984-11-30
KR840004428A (ko) 1984-10-15
IL68497A0 (en) 1983-07-31
DD209833A5 (de) 1984-05-23
NO831473L (no) 1983-10-28
PT76595A (fr) 1983-05-01
SE8302347D0 (sv) 1983-04-26
GB2133401A (en) 1984-07-25
IT1167123B (it) 1987-05-13
NL8301476A (nl) 1983-11-16
PT76595B (fr) 1986-01-21
ES8405796A1 (es) 1984-06-16
DE3315106A1 (de) 1983-11-03
FR2525603B1 (enExample) 1984-09-14
AU1395383A (en) 1983-11-03
ZA832927B (en) 1984-06-27
DK183583D0 (da) 1983-04-26
JPS5910584A (ja) 1984-01-20
GR78481B (enExample) 1984-09-27
GB8311508D0 (en) 1983-06-02
LU84770A1 (fr) 1984-11-28
BE896572A (fr) 1983-10-26
ES521895A0 (es) 1984-06-16
ATA125383A (de) 1986-05-15
FR2525603A1 (fr) 1983-10-28
GB2133401B (en) 1985-10-23
IT8348155A0 (it) 1983-04-26
MA19783A1 (fr) 1983-12-31

Similar Documents

Publication Publication Date Title
DK183583A (da) Fremgangsmaade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner
NO942415L (no) Fremgangsmåte for fremstilling av behandling av surgass og hydrokarbonvæskeströmmer
CA2126305A1 (en) New treatments using venlafaxine
DK0754301T3 (da) Fremstilling og stabilisering af cellesuspensioner
GB857576A (en) Substituted biguanides
ES410174A1 (es) Procedimiento para la preparacion de etambutol.
DE3376190D1 (de) N-azidophenylsulfonyl-n'-pyrimidinyl- and -triazinyl urea
ES446598A1 (es) Procedimiento de preparacion de compuestos piperazinicos.
SE7602838L (sv) Saltbad for stortkylning av badnitrerade konstruktionselement
JPS57156411A (en) Hair-treating agent
JPS5781449A (en) Cyclopropanecarboxamide derivative, its preparation and herbicide containinig said derivative as active component
SE7606063L (sv) Forfarande for framstellning av tienopyridininderivat
BR8105438A (pt) Processo para a preparacao de ureias n-sulfeniladas,composicoes fungicidas,processos de combate a fungos e de preparacao de composicoes
JPS5321857A (en) Method of treating ammonia-containing liquid
ATE20349T1 (de) Heterocyclisch substituierte nitrile, ihre herstellung und verwendung als arzneimittel.
DE69402092D1 (de) Herstellung des Natriumsalzes von 1-Amino-1-Cyanamido-2,2-Dicyanoethylen
JPS57145950A (en) Platinum alloy for accessory
JPS5430156A (en) Synthesis of benzamide derivative
JPS5242829A (en) Process for preparation of aminophenol and phenylenediamine
JPS5283533A (en) 6-substituted naphtehalene-2-oxyalkylamines
SU503934A1 (ru) Дисперсионно-твердеющий элинвар
SU532597A1 (ru) Способ кондиционировани сложных удобрений
TH3418A (th) เบนโซอิลเฟนนิลยูเรีย
ES8100295A3 (es) Procedimiento para preparar xantinas sustituidas
JPS57145951A (en) Platinum alloy for accessory

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment